anmelden
25 € WM-Startbonus + 5 € Torbonus für jeden deutschen Treffer*
SPI
19.954,36
PKT
-96,42
PKT
-0,48
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SPI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 05.10.11 | Givaudan hold | Deutsche Bank AG | |
| 05.10.11 | ABB (Asea Brown Boveri) overweight | J.P. Morgan Cazenove | |
| 05.10.11 | Holcim overweight | J.P. Morgan Cazenove | |
| 05.10.11 | Holcim neutral | J.P. Morgan Cazenove | |
| 05.10.11 | UBS overweight | HSBC | |
| 05.10.11 | Lonza hold | Citigroup Corp. | |
| 05.10.11 | Clariant hold | Citigroup Corp. | |
| 05.10.11 | UBS hold | Société Générale Group S.A. (SG) | |
| 05.10.11 | UBS sell | Société Générale Group S.A. (SG) | |
| 05.10.11 | Givaudan hold | Vontobel Research | |
| 04.10.11 | Swatch (I) overweight | HSBC | |
| 04.10.11 | UBS outperform | RBC Capital Markets | |
| 04.10.11 | Givaudan neutral | HSBC | |
| 04.10.11 | Givaudan sell | Citigroup Corp. | |
| 04.10.11 | Zurich Insurance buy | Citigroup Corp. | |
| 04.10.11 | UBS verkaufen | Independent Research GmbH | |
| 04.10.11 | dormakaba buy | UBS AG | |
| 04.10.11 | Schweiter hold | Vontobel Research | |
| 04.10.11 | UBS buy | Vontobel Research | |
| 03.10.11 | Novartis buy | Société Générale Group S.A. (SG) | |
| 03.10.11 | Barry Callebaut hold | Vontobel Research | |
| 03.10.11 | Tecan (N) hold | Vontobel Research | |
| 03.10.11 | Rieter hold | Vontobel Research | |
| 03.10.11 | Implenia hold | Vontobel Research | |
| 30.09.11 | Sonova hold | Vontobel Research | |
| 28.09.11 | Holcim buy | Société Générale Group S.A. (SG) | |
| 28.09.11 | Nestlé buy | Vontobel Research | |
| 28.09.11 | ARYZTA buy | Vontobel Research | |
| 27.09.11 | Novartis kaufen | Hamburger Sparkasse AG (Haspa) | |
| 27.09.11 | Roche kaufen | Hamburger Sparkasse AG (Haspa) | |
| 27.09.11 | ABB (Asea Brown Boveri) kaufen | Hamburger Sparkasse AG (Haspa) | |
| 27.09.11 | Arbonia hold | Vontobel Research | |
| 27.09.11 | Novartis buy | Vontobel Research | |
| 27.09.11 | Lonza hold | Vontobel Research | |
| 27.09.11 | UBS outperform | RBC Capital Markets | |
| 27.09.11 | Rieter hold | Vontobel Research | |
| 27.09.11 | Newron PharmaceuticalsAz. hold | Vontobel Research | |
| 27.09.11 | UBS hold | Société Générale Group S.A. (SG) | |
| 26.09.11 | Novartis buy | Vontobel Research | |
| 26.09.11 | UBS buy | Vontobel Research |